Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Vascular Pharmacology
  4. Fast Track Articles
  5. Fast Track Article
image of Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular Hypertrophy

Abstract

Background

Among the organ damage mediated by hypertension, cardiac lesions hold significant importance. Numerous authors focus on hypertensive heart disease (HHD) rather than exclusively on left ventricular hypertrophy (LVH).

Objective

This narrative review aims to assess the incorporation of the concept of 'hypertensive heart disease' (HHD) in hypertension (HTN) guidelines. Furthermore, if HHD is not addressed, the review will evaluate the potential benefits of including this concept in future studies.

Methods

The following databases were searched: Scopus, Medline, Springer, Science Direct, Wiley, SAGE, Cambridge, Oxford Journals, and Google Scholar. Attention was given to the guidelines related to hypertension(HTN); the search items were “guidelines” and “hypertension.” Within these guidelines, we specifically sought references to ‘hypertensive heart disease.’.

Results

The concept of “HHD” is clearly advantageous compared to “HTN LVH,” as it not only addresses LVH but also considers other structures of the heart that may be severely affected, which can significantly influence treatment. The concept of “hypertensive heart disease” is mentioned in only 8 out of 36 guidelines on HTN. The therapeutic implications and recommendations are absent in the guidelines.

Conclusion

The concept of HHD is reasonable and evidence-based, and there is no reason to focus only on LVH when considering HTN-induced damage to the heart. It is time to update our recommendations for heart treatment by using the phrase “Treatment of hypertensive heart disease” instead of “Treatment of hypertensive LVH.” This update can enhance our awareness of the need to improve not only HTN LVH but the other parts of the heart as well.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cvp/10.2174/0115701611351415241212092014
2025-01-21
2025-06-23

  • From This Site

    /content/journals/cvp/10.2174/0115701611351415241212092014
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. White P.D. The heart in hypertension and in nephritis. Boston Med. Surg. J. 1923 189 25 1015 1018 10.1056/NEJM192312201892502
    [Google Scholar]
  2. Vasan R.S. Song R.J. Xanthakis V. Beiser A. DeCarli C. Mitchell G.F. Seshadri S. Hypertension-mediated organ damage: Prevalence, correlates, and prognosis in the community. Hypertension 2022 79 3 505 515 10.1161/HYPERTENSIONAHA.121.18502 35138872
    [Google Scholar]
  3. Oh J.S. Lee C.H. Park J. Park H.K. Hwang J.K. Hypertension-mediated organ damage and long-term cardiovascular outcomes in asian hypertensive patients without prior cardiovascular disease. J. Korean Med. Sci. 2020 35 48 e400 10.3346/jkms.2020.35.e400 33316856
    [Google Scholar]
  4. Đorđević D.B. Koračević G.P. Đorđević A.D. Lović D.B. Hypertension and left ventricular hypertrophy. J. Hypertens. 2024 42 9 1505 1515 10.1097/HJH.0000000000003774 38747417
    [Google Scholar]
  5. Zdravkovic M. Klasnja S. Popovic M. Djuran P. Mrda D. Ivankovic T. Manojlovic A. Koracevic G. Lovic D. Popadic V. Cardiac magnetic resonance in hypertensive heart disease: time for a new chapter. In: Diagnostics 2022 13 1 137 10.3390/diagnostics13010137 36611429
    [Google Scholar]
  6. Koraćević G. Mićić S. Stojanović M. Zdravkovic M. Simić D. Kostić T. Atanasković V. Janković-Tomašević R. Beta-blockers in hypertensive left ventricular hypertrophy and atrial fibrillation prevention. Curr. Vasc. Pharmacol. 2024 22 1 19 27 10.2174/0115701611264647231110101700 38031765
    [Google Scholar]
  7. Cuspidi C. Giovannini R. Tadic M. Left atrial stiffness: a novel marker of hypertension-mediated organ damage on the horizon? Hypertens. Res. 2021 44 3 365 367 10.1038/s41440‑020‑00582‑1 33257816
    [Google Scholar]
  8. Tackling G. Borhade M.B. Hypertensive Heart Disease. StatPearls. Treasure Island, FL StatPearls Publishing 2024 Available from: https://www.ncbi.nlm.nih.gov/books/NBK539800/
    [Google Scholar]
  9. Kreutz R. Brunström M. Burnier M. Grassi G. Januszewicz A. Muiesan M.L. Tsioufis K. de Pinho R.M. Albini F.L. Boivin J.M. Doumas M. Nemcsik J. Rodilla E. Agabiti-Rosei E. Algharably E.A.E. Agnelli G. Benetos A. Hitij J.B. Cífková R. Cornelissen V. Danser A.H.J. Delles C. Huelgas R.G. Járai Z. Palatini P. Pathak A. Persu A. Polonia J. Sarafidis P. Stergiou G. Thomopoulos C. Wanner C. Weber T. Williams B. Kjeldsen S.E. Mancia G. 2024 european society of hypertension clinical practice guidelines for the management of arterial hypertension. Eur. J. Intern. Med. 2024 126 1 15 10.1016/j.ejim.2024.05.033 38914505
    [Google Scholar]
  10. Hahn L. The P-R segment in hypertensive heart disease. Heart 1940 2 2 101 106 10.1136/hrt.2.2.101 18609837
    [Google Scholar]
  11. Benjamin J.E. The heart disease situation in Cincinnati. Am. Heart J. 1927 2 6 637 648 10.1016/S0002‑8703(27)90212‑9
    [Google Scholar]
  12. Reid W.D. Some toxic effects of digitalis. JAMA 1923 81 6 435 439 10.1001/jama.1923.02650060005002
    [Google Scholar]
  13. Reid W.D. The diagnosis of cardiovascular syphilis. Boston Med. Surg. J. 1923 188 7 189 193 10.1056/NEJM192302151880701
    [Google Scholar]
  14. Dann D.S. Some observations on the value of the index and angle of bordet-vaquez in cardiac examination. Arch. Intern. Med. 1923 31 2 269 288 10.1001/archinte.1923.00110140121012
    [Google Scholar]
  15. Koracevic G. Mićić S. Stojanovic M. Bozinovic N. Simic D. Lović D. Krstic N. Tomašević R.J. Significance of beta-blocker in patients with hypertensive left ventricular hypertrophy and myocardial ischemia. Curr. Vasc. Pharmacol. 2023 21 2 81 90 10.2174/1570161121666230201141215 36722475
    [Google Scholar]
  16. Nemtsova V. Burkard T. Vischer A.S. Hypertensive heart disease: A narrative review series part 2: Macrostructural and functional abnormalities. J. Clin. Med. 2023 12 17 5723 10.3390/jcm12175723 37685790
    [Google Scholar]
  17. Sanchez R.A. Ayala M. Baglivo H. Velazquez C. Burlando G. Kohlmann O. Jimenez J. Jaramillo P.L. Brandao A. Valdes G. Alcocer L. Bendersky M. Ramirez A.J. Zanchetti A. Latin American guidelines on hypertension. J. Hypertens. 2009 27 5 905 922 10.1097/HJH.0b013e32832aa6d2 19349909
    [Google Scholar]
  18. van den Born B.J. Beutler J.J. Gaillard C.A. de Gooijer A. van den Meiracker A.H. Kroon A.A. Dutch guideline for the management of hypertensive crisis -- 2010 revision. Neth. J. Med. 2011 69 5 248 255 21646675
    [Google Scholar]
  19. Aronow W.S. Fleg J.L. Pepine C.J. Artinian N.T. Bakris G. Brown A.S. Ferdinand K.C. Forciea M.A. Frishman W.H. Jaigobin C. Kostis J.B. Mancia G. Oparil S. Ortiz E. Reisin E. Rich M.W. Schocken D.D. Weber M.A. Wesley D.J. Harrington R.A. ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Circulation 2011 123 21 2434 2506 10.1161/CIR.0b013e31821daaf6 21518977
    [Google Scholar]
  20. Mancia G. Fagard R. Narkiewicz K. Redon J. Zanchetti A. Böhm M. Christiaens T. Cifkova R. De Backer G. Dominiczak A. Galderisi M. Grobbee D.E. Jaarsma T. Kirchhof P. Kjeldsen S.E. Laurent S. Manolis A.J. Nilsson P.M. Ruilope L.M. Schmieder R.E. Sirnes P.A. Sleight P. Viigimaa M. Waeber B. Zannad F. Redon J. Dominiczak A. Narkiewicz K. Nilsson P.M. Burnier M. Viigimaa M. Ambrosioni E. Caufield M. Coca A. Olsen M.H. Schmieder R.E. Tsioufis C. van de Borne P. Zamorano J.L. Achenbach S. Baumgartner H. Bax J.J. Bueno H. Dean V. Deaton C. Erol C. Fagard R. Ferrari R. Hasdai D. Hoes A.W. Kirchhof P. Knuuti J. Kolh P. Lancellotti P. Linhart A. Nihoyannopoulos P. Piepoli M.F. Ponikowski P. Sirnes P.A. Tamargo J.L. Tendera M. Torbicki A. Wijns W. Windecker S. Clement D.L. Coca A. Gillebert T.C. Tendera M. Rosei E.A. Ambrosioni E. Anker S.D. Bauersachs J. Hitij J.B. Caulfield M. De Buyzere M. De Geest S. Derumeaux G.A. Erdine S. Farsang C. Funck-Brentano C. Gerc V. Germano G. Gielen S. Haller H. Hoes A.W. Jordan J. Kahan T. Komajda M. Lovic D. Mahrholdt H. Olsen M.H. Ostergren J. Parati G. Perk J. Polonia J. Popescu B.A. Reiner Z. Rydén L. Sirenko Y. Stanton A. Struijker-Boudier H. Tsioufis C. van de Borne P. Vlachopoulos C. Volpe M. Wood D.A. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur. Heart J. 2013 34 28 2159 2219 10.1093/eurheartj/eht151 23771844
    [Google Scholar]
  21. Wolf S.J. Lo B. Shih R.D. Smith M.D. Fesmire F.M. Clinical policy: Critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann. Emerg. Med. 2013 62 1 59 68 10.1016/j.annemergmed.2013.05.012 23842053
    [Google Scholar]
  22. The Egyptian Hypertension Society EGYPTIAN HYPERTENSION GUIDELINES. Egypt. Heart J. 2014 66 2 79 132 10.1016/j.ehj.2014.03.001
    [Google Scholar]
  23. James P.A. Oparil S. Carter B.L. Cushman W.C. Dennison-Himmelfarb C. Handler J. Lackland D.T. LeFevre M.L. MacKenzie T.D. Ogedegbe O. Smith S.C. Jr Svetkey L.P. Taler S.J. Townsend R.R. Wright J.T. Jr Narva A.S. Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 311 5 507 520 10.1001/jama.2013.284427 24352797
    [Google Scholar]
  24. Weber M.A. Schiffrin E.L. White W.B. Mann S. Lindholm L.H. Kenerson J.G. Flack J.M. Carter B.L. Materson B.J. Ram C.V.S. Cohen D.L. Cadet J.C. Jean-Charles R.R. Taler S. Kountz D. Townsend R. Chalmers J. Ramirez A.J. Bakris G.L. Wang J. Schutte A.E. Bisognano J.D. Touyz R.M. Sica D. Harrap S.B. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J. Hypertens. 2014 32 1 3 15 10.1097/HJH.0000000000000065 24270181
    [Google Scholar]
  25. Seedat Y.K. Rayner B.L. Veriava Y. South African hypertension practice guideline 2014 : review article. Cardiovasc. J. Afr. 2014 25 6 288 294 10.5830/CVJA‑2014‑062 25629715
    [Google Scholar]
  26. Tykarski A. Narkiewicz K. Gaciong Z. Januszewicz A. Litwin M. Kostka-Jeziorny K. Adamczak M. Szczepaniak-Chicheł L. Chrostowska M. Czarnecka D. Dzida G. Filipiak K.J. Gąsowski J. Głuszek J. Grajek S. Grodzicki T. Kawecka-Jaszcz K. Wożakowska-Kapłon B. Begier-Krasińska B. Manitius J. Myśliwiec M. Niemirska A. Prejbisz A. Pupek-Musialik D. Brzezińska-Rajszys G. Stolarz-Skrzypek K. Szadkowska A. Tomasik T. Widecka K. Więcek A. Windak A. Wolf J. Zdrojewski T. Żurowska A. 2015 guidelines for the management of hypertension. Recommendations of the polish society of hypertension — short version. Kardiol. Pol. 2015 73 8 676 700 10.5603/KP.2015.0157 26304155
    [Google Scholar]
  27. Gabb G.M. Mangoni A.A. Anderson C.S. Cowley D. Dowden J.S. Golledge J. Hankey G.J. Howes F.S. Leckie L. Perkovic V. Schlaich M. Zwar N.A. Medley T.L. Arnolda L. Guideline for the diagnosis and management of hypertension in adults — 2016. Med. J. Aust. 2016 205 2 85 89 10.5694/mja16.00526 27456450
    [Google Scholar]
  28. Malachias M.V.B. Barbosa E.C.D. Martim J.F. Rosito G.B.A. Toledo J.Y. Passarelli O. 7th brazilian guideline of arterial hypertension: chapter 14 - hypertensive crisis. Arq. Bras. Cardiol. 2016 107 3 Suppl. 3 79 83 10.5935/abc.20160164 27819393
    [Google Scholar]
  29. Whelton P.K. Carey R.M. Aronow W.S. Casey D.E. Jr Collins K.J. Dennison Himmelfarb C. DePalma S.M. Gidding S. Jamerson K.A. Jones D.W. MacLaughlin E.J. Muntner P. Ovbiagele B. Smith S.C. Jr Spencer C.C. Stafford R.S. Taler S.J. Thomas R.J. Williams K.A. Sr Williamson J.D. Wright J.T. Jr 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J. Am. Coll. Cardiol. 2018 71 19 e127 e248 10.1016/j.jacc.2017.11.006 29146535
    [Google Scholar]
  30. Tay J.C. Sule A.A. Chew E.K. Tey J.S. Lau T. Lee S. Lee S.H. Leong C.K. Lim S.T. Low L.P. Oh V.M. Phoon K.Y. Tan K.W. Wu A. Yeo L.S. Ministry of health clinical practice guidelines: hypertension. Singapore Med. J. 2018 59 1 17 27 10.11622/smedj.2018007 29376186
    [Google Scholar]
  31. Developed by the Division of Non-Communicable Diseases - Ministry of Health 2018 Kenya national guidelines for cardiovascular diseases management. Available from: www.health.go.ke
    [Google Scholar]
  32. South East Sydney Local Health District. 2018 Available from: https://www.seslhd.health.nsw.gov.au/sites/default/files/documents/SESLHDGL068.pdf
  33. Joint committee for guideline revision 2018 chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of chinese guidelines for prevention and treatment of hypertension. J. Geriatr. Cardiol. 2019 16 3 182 241 10.11909/j.issn.1671‑5411.2019.03.014 31080465
    [Google Scholar]
  34. This new tabular display format follows closely that of the Ministry of Health (MOH) website CPG section. 2018 Available from: http://www.acadmed.org.my/index.cfm?menuid=67
  35. Williams B. Mancia G. Spiering W. Agabiti Rosei E. Azizi M. Burnier M. Clement D.L. Coca A. de Simone G. Dominiczak A. Kahan T. Mahfoud F. Redon J. Ruilope L. Zanchetti A. Kerins M. Kjeldsen S.E. Kreutz R. Laurent S. Lip G.Y.H. McManus R. Narkiewicz K. Ruschitzka F. Schmieder R.E. Shlyakhto E. Tsioufis C. Aboyans V. Desormais I. De Backer G. Heagerty A.M. Agewall S. Bochud M. Borghi C. Boutouyrie P. Brguljan J. Bueno H. Caiani E.G. Carlberg B. Chapman N. Cífková R. Cleland J.G.F. Collet J-P. Coman I.M. de Leeuw P.W. Delgado V. Dendale P. Diener H-C. Dorobantu M. Fagard R. Farsang C. Ferrini M. Graham I.M. Grassi G. Haller H. Hobbs F.D.R. Jelakovic B. Jennings C. Katus H.A. Kroon A.A. Leclercq C. Lovic D. Lurbe E. Manolis A.J. McDonagh T.A. Messerli F. Muiesan M.L. Nixdorff U. Olsen M.H. Parati G. Perk J. Piepoli M.F. Polonia J. Ponikowski P. Richter D.J. Rimoldi S.F. Roffi M. Sattar N. Seferovic P.M. Simpson I.A. Sousa-Uva M. Stanton A.V. van de Borne P. Vardas P. Volpe M. Wassmann S. Windecker S. Zamorano J.L. Windecker S. Aboyans V. Agewall S. Barbato E. Bueno H. Coca A. Collet J-P. Coman I.M. Dean V. Delgado V. Fitzsimons D. Gaemperli O. Hindricks G. Iung B. Jüni P. Katus H.A. Knuuti J. Lancellotti P. Leclercq C. McDonagh T.A. Piepoli M.F. Ponikowski P. Richter D.J. Roffi M. Shlyakhto E. Simpson I.A. Sousa-Uva M. Zamorano J.L. Tsioufis C. Lurbe E. Kreutz R. Bochud M. Rosei E.A. Jelakovic B. Azizi M. Januszewics A. Kahan T. Polonia J. van de Borne P. Williams B. Borghi C. Mancia G. Parati G. Clement D.L. Coca A. Manolis A. Lovic D. Benkhedda S. Zelveian P. Siostrzonek P. Najafov R. Pavlova O. De Pauw M. Dizdarevic-Hudic L. Raev D. Karpettas N. Linhart A. Olsen M.H. Shaker A.F. Viigimaa M. Metsärinne K. Vavlukis M. Halimi J-M. Pagava Z. Schunkert H. Thomopoulos C. Páll D. Andersen K. Shechter M. Mercuro G. Bajraktari G. Romanova T. Trušinskis K. Saade G.A. Sakalyte G. Noppe S. DeMarco D.C. Caraus A. Wittekoek J. Aksnes T.A. Jankowski P. Polonia J. Vinereanu D. Baranova E.I. Foscoli M. Dikic A.D. Filipova S. Fras Z. Bertomeu-Martínez V. Carlberg B. Burkard T. Sdiri W. Aydogdu S. Sirenko Y. Brady A. Weber T. Lazareva I. Backer T.D. Sokolovic S. Jelakovic B. Widimsky J. Viigimaa M. Pörsti I. Denolle T. Krämer B.K. Stergiou G.S. Parati G. Trušinskis K. Miglinas M. Gerdts E. Tykarski A. de Carvalho Rodrigues M. Dorobantu M. Chazova I. Lovic D. Filipova S. Brguljan J. Segura J. Gottsäter A. Pechère-Bertschi A. Erdine S. Sirenko Y. Brady A. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018 39 33 3021 3104 10.1093/eurheartj/ehy339 30165516
    [Google Scholar]
  36. Lee H.Y. Shin J. Kim G.H. Park S. Ihm S.H. Kim H.C. Kim K. Kim J.H. Lee J.H. Park J.M. Pyun W.B. Chae S.C. 2018 korean society of hypertension guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin. Hypertens. 2019 25 1 20 10.1186/s40885‑019‑0124‑x 31388453
    [Google Scholar]
  37. van den Born B.J.H. Lip G.Y.H. Brguljan-Hitij J. Cremer A. Segura J. Morales E. Mahfoud F. Amraoui F. Persu A. Kahan T. Agabiti Rosei E. de Simone G. Gosse P. Williams B. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur. Heart J. Cardiovasc. Pharmacother. 2019 5 1 37 46 10.1093/ehjcvp/pvy032 30165588
    [Google Scholar]
  38. Umemura S. Arima H. Arima S. Asayama K. Dohi Y. Hirooka Y. Horio T. Hoshide S. Ikeda S. Ishimitsu T. Ito M. Ito S. Iwashima Y. Kai H. Kamide K. Kanno Y. Kashihara N. Kawano Y. Kikuchi T. Kitamura K. Kitazono T. Kohara K. Kudo M. Kumagai H. Matsumura K. Matsuura H. Miura K. Mukoyama M. Nakamura S. Ohkubo T. Ohya Y. Okura T. Rakugi H. Saitoh S. Shibata H. Shimosawa T. Suzuki H. Takahashi S. Tamura K. Tomiyama H. Tsuchihashi T. Ueda S. Uehara Y. Urata H. Hirawa N. The japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens. Res. 2019 42 9 1235 1481 10.1038/s41440‑019‑0284‑9 31375757
    [Google Scholar]
  39. Hua Q. Fan L. Li J. 2019 Chinese guideline for the management of hypertension in the elderly. J. Geriatr. Cardiol. 2019 16 2 67 99 10.11909/j.issn.1671‑5411.2019.02.001 30923539
    [Google Scholar]
  40. Alcocer L. Álvarez-López H. Borrayo-Sánchez G.B. Cardona-Muñoz E.G. Chávez-Mendoza A. Hypertension as a persistent public health problem. A position paper from Alliance for a Healthy Heart, Mexico. Annals of Clinical Hypertension 2019 3 1 009 030 10.29328/journal.ach.1001015
    [Google Scholar]
  41. Shah S.N. Munjal Y.P. Kamath S.A. Wander G.S. Mehta N. Mukherjee S. Kirpalani A. Gupta P. Shah H. Rohatgi R. Billimoria A.R. Maiya M. Das M.K. Goswami K.C. Sharma R. Rajapurkar M.M. Chawla R. Saboo B. Jha V. Indian guidelines on hypertension-IV (2019). J. Hum. Hypertens. 2020 34 11 745 758 10.1038/s41371‑020‑0349‑x 32427886
    [Google Scholar]
  42. Hypertension in adults: diagnosis and management. 2019 Available from: www.nice.org.uk/guidance/ng136 (Accessed on: 21 November 2023).
  43. Vilela-Martin JF Yugar-Toledo JC Rodrigues MC Luso-brazilian position statement on hypertensive emergencies - 2020. Arq. Bras. Cardiol. 2020 114 4 736 751 10.36660/abc.20190731 32491016
    [Google Scholar]
  44. Rabi D.M. McBrien K.A. Sapir-Pichhadze R. Nakhla M. Ahmed S.B. Dumanski S.M. Butalia S. Leung A.A. Harris K.C. Cloutier L. Zarnke K.B. Ruzicka M. Hiremath S. Feldman R.D. Tobe S.W. Campbell T.S. Bacon S.L. Nerenberg K.A. Dresser G.K. Fournier A. Burgess E. Lindsay P. Rabkin S.W. Prebtani A.P.H. Grover S. Honos G. Alfonsi J.E. Arcand J. Audibert F. Benoit G. Bittman J. Bolli P. Côté A.M. Dionne J. Don-Wauchope A. Edwards C. Firoz T. Gabor J.Y. Gilbert R.E. Grégoire J.C. Gryn S.E. Gupta M. Hannah-Shmouni F. Hegele R.A. Herman R.J. Hill M.D. Howlett J.G. Hundemer G.L. Jones C. Kaczorowski J. Khan N.A. Kuyper L.M. Lamarre-Cliche M. Lavoie K.L. Leiter L.A. Lewanczuk R. Logan A.G. Magee L.A. Mangat B.K. McFarlane P.A. McLean D. Michaud A. Milot A. Moe G.W. Penner S.B. Pipe A. Poppe A.Y. Rey E. Roerecke M. Schiffrin E.L. Selby P. Sharma M. Shoamanesh A. Sivapalan P. Townsend R.R. Tran K. Trudeau L. Tsuyuki R.T. Vallée M. Woo V. Bell A.D. Daskalopoulou S.S. Hypertension canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can. J. Cardiol. 2020 36 5 596 624 10.1016/j.cjca.2020.02.086 32389335
    [Google Scholar]
  45. BCGuidelines. 2020 Available from: https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/hypertension
  46. Tschanz C.M.P. Cushman W.C. Harrell C.T.E. Berlowitz D.R. Sall J.L. Synopsis of the 2020 U.S. department of veterans affairs/u.s. department of defense clinical practice guideline: the diagnosis and management of hypertension in the primary care setting. Ann. Intern. Med. 2020 173 11 904 913 10.7326/M20‑3798 32866417
    [Google Scholar]
  47. Wyss F. Coca A. Lopez-Jaramillo P. Ponte-Negretti C. Wyss F.S. Restrepo G. Ponte-Negretti C.I. Lanas F. Pérez G. Sebba Barroso W. de la Noval R. Paris J.V. Almonte C. Valdez O. Gonzales Medina Á. Valoy L.V. Puente Barragán A.C. Cobos L. Ullauri V. Lara Terán J. Sosa Liprandi Á. Piskorz D. Barbosa E. López Jaramillo P. Parati G. Coca A. Iñiguez A. Position statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017–2020. Int. J. Cardiol. Hypertens. 2020 6 100041 10.1016/j.ijchy.2020.100041 33447767
    [Google Scholar]
  48. Unger T. Borghi C. Charchar F. Khan N.A. Poulter N.R. Prabhakaran D. Ramirez A. Schlaich M. Stergiou G.S. Tomaszewski M. Wainford R.D. Williams B. Schutte A.E. 2020 international society of hypertension global hypertension practice guidelines. Hypertension 2020 75 6 1334 1357 10.1161/HYPERTENSIONAHA.120.15026 32370572
    [Google Scholar]
  49. Interim guidelines for the clinical management of hypertension in Jamaica 2020 Available from: https://www.moh.gov.jm/wp-content/uploads/2020/10/HYPERTENSIONGUIDELINES_Interim_final.pdf
    [Google Scholar]
  50. Van Minh H. Van Huy T. Long D.P.P. Tien H.A. Highlights of the 2022 vietnamese society of hypertension guidelines for the diagnosis and treatment of arterial hypertension. J. Clin. Hypertens. 2022 24 9 1121 1138 10.1111/jch.14580 36196473
    [Google Scholar]
  51. Kim H.L. Lee E.M. Ahn S.Y. Kim K. Kim H.C. Kim J.H. Lee H.Y. Lee J.H. Park J.M. Cho E.J. Park S. Shin J. Kim Y.K. The 2022 focused update of the 2018 korean hypertension society guidelines for the management of hypertension. Clin. Hypertens. 2023 29 1 11 10.1186/s40885‑023‑00234‑9 36788612
    [Google Scholar]
  52. Mancia G. Kreutz R. Brunström M. Burnier M. Grassi G. Januszewicz A. Muiesan M.L. Tsioufis K. Agabiti-Rosei E. Algharably E.A.E. Azizi M. Benetos A. Borghi C. Hitij J.B. Cifkova R. Coca A. Cornelissen V. Cruickshank J.K. Cunha P.G. Danser A.H.J. Pinho R.M. Delles C. Dominiczak A.F. Dorobantu M. Doumas M. Fernández-Alfonso M.S. Halimi J.M. Járai Z. Jelaković B. Jordan J. Kuznetsova T. Laurent S. Lovic D. Lurbe E. Mahfoud F. Manolis A. Miglinas M. Narkiewicz K. Niiranen T. Palatini P. Parati G. Pathak A. Persu A. Polonia J. Redon J. Sarafidis P. Schmieder R. Spronck B. Stabouli S. Stergiou G. Taddei S. Thomopoulos C. Tomaszewski M. Van de Borne P. Wanner C. Weber T. Williams B. Zhang Z.Y. Kjeldsen S.E. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the european society of hypertension. J. Hypertens. 2023 41 12 1874 2071 10.1097/HJH.0000000000003480 37345492
    [Google Scholar]
  53. Islam S.M.S. Daryabeygi-Khotbehsara R. Ghaffari M.P. Uddin R. Gao L. Xu X. Siddiqui M.U. Livingstone K.M. Siopis G. Sarrafzadegan N. Schlaich M. Maddison R. Huxley R. Schutte A.E. Burden of hypertensive heart disease and high systolic blood pressure in australia from 1990 to 2019: results from the global burden of diseases study. Heart Lung Circ. 2023 32 10 1178 1188 10.1016/j.hlc.2023.06.853 37743220
    [Google Scholar]
  54. Lu Y. Lan T. Global, regional, and national burden of hypertensive heart disease during 1990–2019: an analysis of the global burden of disease study 2019. BMC Public Health 2022 22 1 841 10.1186/s12889‑022‑13271‑0 35473603
    [Google Scholar]
  55. Westaby J.D. Miles C. Chis Ster I. Cooper S.T.E. Antonios T.F. Meijles D. Behr E.R. Sheppard M.N. Characterisation of hypertensive heart disease: pathological insights from a sudden cardiac death cohort to inform clinical practice. J. Hum. Hypertens. 2022 36 3 246 253 10.1038/s41371‑021‑00507‑6 33654238
    [Google Scholar]
  56. Verdecchia P. Angeli F. Cavallini C. Aita A. Turturiello D. De Fano M. Reboldi G. Sudden cardiac death in hypertensive patients. Hypertension 2019 73 5 1071 1078 10.1161/hypertensionaha.119.12684 30827144
    [Google Scholar]
  57. Koracevic G. Perisic Z. Stanojkovic M. Stojanovic M. Zdravkovic M. Tomasevic M. Djordjevic D. Mladenovic K. Koracevic M. Trkulja J. A discrepancy: calcium channel blockers are effective for the treatment of hypertensive left ventricular hypertrophy but not as effective for prevention of heart failure. Med. Princ. Pract. 2022 31 5 454 462 10.1159/000526792 36044874
    [Google Scholar]
  58. Ekström M. Hellman A. Hasselström J. Hage C. Kahan T. Ugander M. Wallén H. Persson H. Linde C. The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study. ESC Heart Fail. 2020 7 2 737 746 10.1002/ehf2.12612 32073753
    [Google Scholar]
  59. Scarsoglio S. Guala A. Camporeale C. Ridolfi L. Impact of atrial fibrillation on the cardiovascular system through a lumped-parameter approach. Med. Biol. Eng. Comput. 2014 52 11 905 920 10.1007/s11517‑014‑1192‑4 25192922
    [Google Scholar]
  60. Sohara H. Amitani S. Kurose M. Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J. Am. Coll. Cardiol. 1997 29 1 106 112 10.1016/S0735‑1097(96)00427‑5 8996302
    [Google Scholar]
  61. Chao T.F. Potpara T.S. Lip G.Y.H. Atrial fibrillation: stroke prevention. Lancet Reg. Health Eur. 2024 37 100797 10.1016/j.lanepe.2023.100797 38362551
    [Google Scholar]
  62. Enga K.F. Rye-Holmboe I. Hald E.M. Løchen M.L. Mathiesen E.B. Njølstad I. Wilsgaard T. Braekkan S.K. Hansen J.B. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study. J. Thromb. Haemost. 2015 13 1 10 16 10.1111/jth.12762 25330989
    [Google Scholar]
  63. Koracevic G. Stojanovic M. Lovic D. Zdravkovic M. Sakac D. Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk. J. Hum. Hypertens. 2021 35 7 564 576 10.1038/s41371‑021‑00505‑8 33654234
    [Google Scholar]
  64. Ottosen C.I. Nadruz W. Inciardi R.M. Johansen N.D. Fudim M. Biering-Sørensen T. Diastolic dysfunction in hypertension: a comprehensive review of pathophysiology, diagnosis, and treatment. Eur. Heart J. Cardiovasc. Imaging 2024 25 11 1525 1536 10.1093/ehjci/jeae178 39018386
    [Google Scholar]
  65. Tadic M. Cuspidi C. Plein S. Milivojevic I.G. Wang D.W. Grassi G. Mancia G. Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus. Heart Fail. Rev. 2021 26 6 1383 1390 10.1007/s10741‑020‑09943‑x 32170529
    [Google Scholar]
/content/journals/cvp/10.2174/0115701611351415241212092014
Loading
Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular Hypertrophy
Bentham Science Publishers ; https://doi.org/10.2174/0115701611351415241212092014
/content/journals/cvp/10.2174/0115701611351415241212092014
/content/journals/cvp/10.2174/0115701611351415241212092014
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: heart failure ; left ventricular hypertrophy ; Arterial hypertension ; left atrium ; hypertension-mediated organ damages ; hypertensive heart disease

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test